eGPA and Local Inflammation Within the Ear, Nose and Throat Area
Conditions: EGPA - Eosinophilic Granulomatosis With Polyangiitis Interventions: Diagnostic Test: laboratory experiments before and after mepolizumab treatment Sponsors: University Medical Center Groningen; GlaxoSmithKline Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Alleviation of Common Cold Symptoms
Conditions: Common Cold; Pharyngitis; Fever; Congestion; Rhinorrhea; Cough; Sore-throat; Sore Throats Viral; Malaise; Headache; Runny Nose; Sneezing Interventions: Drug: Wintergreen Throat Spray and Aspirin Tablet; Drug: Aspirin Throat Spray and Placebo Tablet; Dietary Supplement: Wintergreen Throat Spray and Placebo Tablet; Other: Placebo Throat Spray and Placebo Tablet Sponsors: Applied Biological Laboratories Inc; Econometrica, Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer
Conditions: Laryngeal Cancer; Hypopharyngeal Cancer Intervention: Other: Voice recording, ENT (Ear, Nose and Throat) examination including transnasal fiberendoscopy, and VHI-30-questionnaire Sponsor: Insel Gruppe AG, University Hospital Bern Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2023 Category: Research Source Type: clinical trials
The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer
Conditions: Laryngeal Cancer; Hypopharyngeal Cancer Intervention: Other: Voice recording, ENT (Ear, Nose and Throat) examination including transnasal fiberendoscopy, and VHI-30-questionnaire Sponsor: University Hospital Inselspital, Berne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2023 Category: Research Source Type: clinical trials
A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis —ICE-COVID
DiscussionThis is a single-centre, phase III, double-blind, randomised placebo-controlled clinical trial to assess whether carrageenan nasal and throat spray reduces the risk of development and severity of COVID-19. If proven effective, the self-administered prophylactic spray would have wider utility for key workers and the general population.Trial registrationNCT04590365;ClinicalTrials.gov NCT04590365. Registered on 19 October 2020. (Source: Trials)
Source: Trials - September 15, 2022 Category: Research Source Type: clinical trials
Cost-effectiveness of a smartphone Application for Tinnitus Treatment (the CATT trial): a study protocol of a randomised controlled trial
This study is designed as a single-blind two-arm 1:1 randomised controlled trial (RCT). Adult patients diagnosed with ST, without psychiatric comorbidities and with experience in using a smartphone, will be recruited at the Ear Nose Throat (ENT) department of the Antwerp University Hospital (UZA). Patients will be randomised into two groups. The experimental group will receive the blended physiotherapy program comprising six in-clinic physiotherapy sessions over a period of 12 weeks (1x/2 weeks) and an exercise and counselling program provided by the smartphone application. The control group will receive the standard ca...
Source: Trials - May 23, 2022 Category: Research Source Type: clinical trials
